[Interview with Prof. Franz-Joseph Krozingen: Interventional cardiology on the success course].
Neumann
Franz-Josef
FJ
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D002309:Cardiology / Q000639:trends*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004630:Emergencies; D005342:Fibrinolysis; D005544:Forecasting; D006801:Humans; D007902:Length of Stay; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D058919:Purinergic P2 Receptor Antagonists; D015607:Stents; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors
D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine